| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/27/2013 | CN101716157B Metoprolol oral drug composite and preparation method thereof |
| 02/27/2013 | CN101653488B Application of Chinese medicinal composition in preparation of medicament for resisting myocardial stunning |
| 02/27/2013 | CN101653487B Application of Chinese medicinal composition in preparation of medicament for treating acute cerebral infarction |
| 02/27/2013 | CN101622229B Novel pyrrole derivative having ureido group and aminocarbonyl group as substituents |
| 02/27/2013 | CN101618077B Wintergreen barberry root suppository and preparation method thereof |
| 02/27/2013 | CN101486659B Alpha 1-adrenalin receptor antagonist, and preparation and medical use thereof |
| 02/27/2013 | CN101461814B Medicament composition containing losartan and hydrochlorothiazidum |
| 02/27/2013 | CN101439141B Use of longstamen onion bulb in preparing medicament for treating vascular endothelial dysfunction |
| 02/27/2013 | CN101268058B 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives |
| 02/27/2013 | CN101010102B Composition comprising non-oxidizable fatty acid analogoues and plant and/or fish oils |
| 02/26/2013 | US8383650 Organic compounds |
| 02/26/2013 | US8383602 Use of TRIM72 as a target for muscle and heart enhancer |
| 02/26/2013 | US8383158 Methods and compositions to treat myocardial conditions |
| 02/26/2013 | CA2608539C Process for preparing 3.alpha.(.beta.)-7.alpha.(.beta.)-dihydroxy-6.alpha.(.beta.)-alkyl-5.beta.-cholanic acid |
| 02/26/2013 | CA2440775C The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
| 02/26/2013 | CA2324381C An integrin heterodimer and a subunit thereof |
| 02/21/2013 | WO2013025984A2 Cannabinoid receptor treatments |
| 02/21/2013 | WO2013025733A1 Lysophosphatidic acid receptor antagonists |
| 02/21/2013 | WO2013025479A1 Jaml specific binding agents, antibodies, and uses related thereto |
| 02/21/2013 | WO2013025201A1 Method of transforming a meal |
| 02/21/2013 | WO2013024898A1 Heterocyclic derivative and pharmaceutical drug |
| 02/21/2013 | WO2013024376A1 Compositions and methods for the treatment of atherothrombosis |
| 02/21/2013 | WO2013024362A2 Cardiovascular therapeutics |
| 02/21/2013 | WO2013024149A1 Crystalline forms of octahydro-3h-spiro [furo [3, 4-c] quinoline -1, 4 '-pyran] -9-ol |
| 02/21/2013 | WO2013024130A1 Furo[3,4-c]quinoline derivatives, medicaments containing such compounds, their use and process for their preparation |
| 02/21/2013 | WO2013024036A1 Funny current (if) inhibitors for use in a method of treating and preventing heart failure in feline |
| 02/21/2013 | WO2013024002A1 PYRAZOLO[3,4-c]PYRIDINE COMPOUNDS AND METHODS OF USE |
| 02/21/2013 | WO2013023511A1 Triazolopyrimidine derivative and preparation method and use thereof |
| 02/21/2013 | WO2013023439A1 Salt and polymorph of pyrazolopyrimidinone compound and drug composition, preparation method and use thereof |
| 02/21/2013 | WO2013023250A1 Controlled-release formulation |
| 02/21/2013 | WO2013000895A9 Dha and epa in the reduction of oxidative stress |
| 02/21/2013 | WO2012022120A8 Dihydropyrazole compounds |
| 02/21/2013 | WO2011101069A3 1, 8 -naphthyridines as kinase inhibitors |
| 02/21/2013 | US20130046283 Methods and intravascular treatment devices for treatment of atherosclerosis |
| 02/21/2013 | US20130046275 Material and method for treating internal cavities |
| 02/21/2013 | US20130046021 Methods of treating cardiomyopathy, systolic cardiac dysfunction and the symptoms of congestive heart failure with probenecid |
| 02/21/2013 | US20130046020 Eicosapentaenoic acid concentrate |
| 02/21/2013 | US20130046013 Salicylate fatty acid derivatives |
| 02/21/2013 | US20130046007 Selective reduction of allelic variants |
| 02/21/2013 | US20130046004 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 02/21/2013 | US20130046003 Pharmaceutical compositions comprising 4-bromo-n-(imidazolidin-2-ylidene)-1h-benzimidazol-5-amine for treating retinal diseases |
| 02/21/2013 | US20130046001 Pharmaceutical composition for inhibiting apoptosis of neuron or neurodegeneration |
| 02/21/2013 | US20130045997 Pirfenidone therapy and inducers of of cytochrome p450 |
| 02/21/2013 | US20130045991 Neuroprotective modulation of nmda receptor subtype activities |
| 02/21/2013 | US20130045986 Novel compounds as modulators of gpr-119 |
| 02/21/2013 | US20130045978 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 02/21/2013 | US20130045975 Bicyclic heteroaryl inhibitors of pde4 |
| 02/21/2013 | US20130045973 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 02/21/2013 | US20130045966 Method of Lowering Serum Uric Acid Levels With (S)-Tofisopam |
| 02/21/2013 | US20130045963 Cyclohexyl Azetidine Derivatives as JAK Inhibitors |
| 02/21/2013 | US20130045951 Novel Nitroso Compounds as Nitroxyl Donors and Methods of Use Thereof |
| 02/21/2013 | US20130045950 Phosphonate Compounds |
| 02/21/2013 | US20130045946 Sulodexide for use in the treatment of pathologies wherein metalloproteinases are involved |
| 02/21/2013 | US20130045924 Methods of reducing hypoxic stress in a mammal by administering soluble p-selectin |
| 02/21/2013 | US20130045922 Pro-angiogenic fragments of prominin-1 and uses thereof |
| 02/21/2013 | US20130045914 Biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators |
| 02/21/2013 | US20130045520 Double-stranded oligonucleotides |
| 02/21/2013 | US20130045217 Lipidomic biomarkers for atherosclerosis and cardiovascular disease |
| 02/21/2013 | US20130045213 Antibody therapy for modulating function of intestinal receptors and methods of treating diabetes and obesity |
| 02/21/2013 | US20130045193 Compositions and methods for the prevention of cardiovascular disease |
| 02/21/2013 | US20130045187 Methods and compositions of producing patient-specific multipotent neuronal stem cells |
| 02/21/2013 | US20130045186 Method of Detecting and/or Identifying Adeno-Associated Virus (AAV) Sequences and Isolating Novel Sequences Identified Thereby |
| 02/21/2013 | US20130045183 Boswellia oil, its fractions and compositions for enhancing brain function |
| 02/21/2013 | US20130045160 Magnetic Nano-Composite for Contrast Agent, Intelligent Contrast Agent, Drug Delivery Agent for Simultaneous Diagnosis and Treatment, and Separation Agent for Target Substance |
| 02/21/2013 | CA2845617A1 Cardiovascular therapeutics |
| 02/21/2013 | CA2845250A1 Salt and polymorph of pyrazolopyrimidinone compound, and pharmaceutical composition containing the same, preparation method and use thereof |
| 02/21/2013 | CA2845228A1 Controlled-release formulation |
| 02/21/2013 | CA2844982A1 Lysophosphatidic acid receptor antagonists |
| 02/21/2013 | CA2844823A1 Method of transforming a meal |
| 02/21/2013 | CA2844794A1 Heterocyclic derivative and pharmaceutical |
| 02/21/2013 | CA2843100A1 Funny current (if) inhibitors for use in a method of treating and preventing heart failure in feline |
| 02/21/2013 | CA2838784A1 Pyrazolo[3,4-c]pyridine compounds and methods of use |
| 02/20/2013 | EP2559755A2 Method for preparation of a cardiomyocyte matrix |
| 02/20/2013 | EP2559705A2 Anti-activin a antibodies and uses thereof |
| 02/20/2013 | EP2559442A1 Method for regulating microrna content in organisms and uses thereof |
| 02/20/2013 | EP2559435A1 Rotigotine in the treatment of hemispatial neglect, stroke and deficits following stroke |
| 02/20/2013 | EP2558467A1 Aryl - /heteroaryl - cyclohexenyl - tetraazabenzo [e]azulenes as vasopressin antagonists |
| 02/20/2013 | EP2558462A1 Pyridyl-vinyl pyrazoloquinolines as par1 inhibitors |
| 02/20/2013 | EP2558103A1 Pharmaceutical composition for treating macular edema |
| 02/20/2013 | EP2558084A2 Combination of vitamin k and nicotinamide |
| 02/20/2013 | CN102939289A Substituted 5-fluoro-1h-pyrazolopyridines and use thereof |
| 02/20/2013 | CN102939283A Indazole compounds useful as ketohexokinase inhibitors |
| 02/20/2013 | CN102939090A Antagonists of mirna-29 expression and their use in the prevention and treatment of aortic aneurysms |
| 02/20/2013 | CN102939087A Novel indazole derivative or salt thereof, manufacturing intermediate therefor, antioxidant using same, and use for an indazole derivative or salt thereof |
| 02/20/2013 | CN102936553A Hawthorn fruit wine and preparation method thereof |
| 02/20/2013 | CN102936250A 稠合双环mTOR抑制剂 Fused bicyclic inhibitors of mTOR |
| 02/20/2013 | CN102935208A Preparation method of angelica sinensis collateral activating tablet |
| 02/20/2013 | CN102935195A Traditional Chinese medicine composition for treating coronary heart disease as well as preparation method and application thereof |
| 02/20/2013 | CN102935189A Medicament for treating arterial and venous embolism |
| 02/20/2013 | CN102935178A Chinese medicine preparation for treating cerebral arteriosclerosis |
| 02/20/2013 | CN102935170A Chinese medicament for treating suppurative pylephlebitis |
| 02/20/2013 | CN102935158A Externally applied medicine for treating haememorrhoids |
| 02/20/2013 | CN102935155A Traditional Chinese medicine preparation for treating stroke and preparation process |
| 02/20/2013 | CN102935153A Qi reinforcing qianzheng pills for cerebral thrombosis disease treatment |
| 02/20/2013 | CN102935150A Preparation method of apocynum venetum antihypertensive effervescent tablet |
| 02/20/2013 | CN102935137A Chinese medicinal composition for treating hypertension |
| 02/20/2013 | CN102935125A Externally applied Chinese herbal composition with facial redness removing effect, preparation and method for preparing externally applied Chinese herbal composition with facial redness removing effect |
| 02/20/2013 | CN102935118A Traditional Chinese medicine composite for treating piles and preparation method of traditional Chinese medicine composite |
| 02/20/2013 | CN102935103A Preparation method for effervescent tablet containing pueraria mirifica flavone |
| 02/20/2013 | CN102935102A Method for simultaneously producing honeysuckle flower distillate and various active substances |